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Abstract 
Background: Schistosomiasis is a severe parasitic infestation with debilitating complications and is the third most 
devastating tropical disease in the world. It is one of the neglected tropical diseases (NTDs) with a high disease-
burden. We present two rare cases of bladder outlet obstruction: one which led to a chronic kidney disease and 
ultimately death and a second which recovered after treatment with praziquantel.
Case presentations: A 72 year old male presented with lower urinary tract symptoms which culminated in an 
episode of acute urinary retention. The patient had never received preventive chemotherapy with praziquantel. After 
suprapubic aspiration, the cause of the obstructive uropathy was found to be several mature live worms of Schisto-
soma haematobium. Despite treatment with praziquantel and haemodialysis; we lost the patient due to sepsis from 
a urinary tract infection. In the second case, a 15 year old male presented with LUTS for a 1 year duration and was 
diagnosed to have schistosomiasis after eggs of Schistosoma haematobium were found in his urine. He was treated 
with praziquantel.
Conclusion: There are several gaps in the public health policies in place to control this NTD in Cameroon as annual 
distribution of preventive chemotherapy is inadequate due to inaccessibility of some high-endemic zones and is 
based on data obtained two decades ago. Population education is insufficient leading to poor health-seeking behav-
iour. These gaps in public health policies need to be addressed to aid in the overall achievement of the sustainable 
development goals.
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Background
Schistosomiasis (Bilharziasis) is a parasitic infestation 
associated with a high degree of morbidity and mortality 
in third world countries, especially in Africa [1]. Schis-
tosomiasis is endemic in some regions in Africa; of the 
261 million people who required preventive treatment 
for the disease in 2013, 90% resided in this continent. In 
Cameroon, five million people are estimated to be at risk 
of infection with the disease, with two million current 
infections [2]. So far, three species have been identi-
fied as causative agents of schistosomiasis in Cameroon: 
Schistosoma mansoni, Schistosoma haematobium and 
Schistosoma guineensis (the Lower Guinea species) [3]. 
Two-third of the cases of schistosomiasis are caused by S. 
haematobium: the species causing urogenital schistoso-
miasis [4]. In this case series, we present two rare cases 
of bladder outlet obstruction caused by S. haematobium; 
one which led to a chronic kidney disease and ultimately 
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Case presentations
Case 1
A 72 year old African male from Wum, in the far North 
west region of Cameroon, presented with a 3 year history 
of lower urinary tract symptoms (LUTS) both obstruc-
tive and irritative in nature; and an International Prostate 
Symptom Score (IPSS) of 22 with a moderate degree of 
bother, which culminated in an episode of acute urinary 
retention for which he sought a consult at our health ser-
vices. The patient like most in his neighbourhood used 
water from a nearby stream for his baths and claims he 
had never received any preventive chemotherapy against 
schistosomiasis.
On examination, the patient was anxious with a ten-
der, renitent hypogastic swelling which increased the 
zeal to urinate on palpation. A diagnosis of bladder out-
let obstruction due to a benign prostate hypertrophy was 
advocated. Blood samples were collected and a transure-
thral catheter was placed which relieved the symptoms; 
with collection of 800 ml of clear urine.
Results of investigations showed: a normal full blood 
count; prostate specific antigen value of 4.21 ng/dl; nor-
mal size and structure of the prostate on ultrasound; 
serum urea  =  321  mg/dl, serum creatinine  =  3.2  mg/
dl, serum K+  =  6  mEq/l and a microscopic haematu-
ria on urinalysis. A follow up renal ultrasound showed a 
decrease in the size of the kidneys.
On day 2, the patient started having macroscopic 
hematuria with blockage of urinary catheter. A suprapu-
bic puncture was done with extraction of several live 
worms which were confirmed to be S. haematobium in 
the laboratory (Fig.  1). The patient was then placed on 
praziquantel 40 mg/kg and hemodialysis.
Day 6 of hospitalization was marked by the onset of 
pyuria and fever and the patient was placed on broad 
spectrum antibiotics and a urine culture requested. We 
finally lost the patient on day 9 of admission due to sepsis 
from a urinary tract infection.
Case 2
A 15 year old African male from Fundong in the North 
west region of Cameroon, presented with a 1  year his-
tory of macroscopic haematuria and dysuria associated 
with obstructive and irritative LUTS (weak stream, inter-
mittency and frequency), an IPSS of 15 and a moderate 
degree of bother. He had consulted severally in the health 
centres in this region by nurses and received multiple 
treatment with broad spectrum antibiotics. He frequently 
swam in a river near his home like most children of his 
age and he had never received any preventive chemo-
therapy. On examination, the patient had a good general 
state with normal vital signs. He had mild suprapubic 
tenderness. Results of investigations revealed a normal 
FBC; Urinalysis: presence of red blood cells, white blood 
cells and eggs of S. haematobium and serum creatinine: 
0.8  mg/dl. He was treated with praziquatel 40  mg/kg 
which relieved the symptoms. He presented 1  month 
later for a follow-up visit with no further complaints.
Discussion
Schistosomiasis, sometimes known as bilharziasis or 
snail fever is a water borne disease transmitted through 
skin contact with infested fresh water bodies. According 
to the World Health Organisation (WHO), schistosomia-
sis is one of the four neglected tropical diseases (NTDs) 
controlled through “preventive chemotherapy” interven-
tion (the others include soil transmitted helminthiasis, 
onchocerciasis and lymphatic filiariasis) [5].
Schistosoma haematobium is the second most com-
mon isolated species in Cameroon, responsible for up to 
95.92% prevalence in some health districts like the Mal-
antouen health district, in the West region [3].
The life cycle of S. haematobium begins with the excre-
tion of the egg into fresh water bodies, after which they 
hatch into the miracidia and penetrate bulinus species 
(the intermediate host). The parasite emerges from the 
snails in the larva stage, penetrating the human skin (the 
definitive host) in contact with the infested water. The 
larvae then migrate to the lungs and liver. The worms 
then mature, copulate, and adult female worms deposit 
their eggs in the pelvic vessels which progressively pen-
etrate urinary and genital system. Eggs deposited during 
the active phase induce a granulomatous reaction with a 
resultant fibrosis [6].
Early manifestations of infection include; cough, fever, 
hepatomegaly, splenomegaly, lymphadenopathies and 
Fig. 1 Urine aspirate from supra-pubic puncture; showing adult 
worms of Schistosoma haematobium (white arrow) and a macroscopic 
haematuria (black arrow)
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difficulty in breathing following an initial pruritic papular 
skin rash (“swimmer’s itch”).
Individuals can develop chronic debilitating complica-
tions years after infestation, which include: haematuria, 
stunting and wasting, bladder cancer, ureteric obstruc-
tion, hydronephrosis, urinary tract infections, renal fail-
ure and ultimately death [7, 8]. Also, S. haematobium is 
associated with high mortality especially in school-aged 
children (7–14 years) [9, 10]. Furthermore, 75% of chron-
ically infected females suffer from female genital schisto-
somiasis which presents with contact bleeding, abnormal 
discharges, dyspareunia and diminished fertility which 
is a potential source of stigmatisation and shame [11]. 
Lastly, the eggs of S. haematobium eggs have been 
reported as Group I carcinogens, causing squamous cell 
carcinoma; and has also been incriminated as a cofactor 
for the transmission of the HIV in Africa [12–14].
From the above complications, it is clear that schisto-
somiasis has a high disease-burden. Despite its public 
health importance, S. haematobium has been labeled 
‘‘the neglected schistosome’’ [15, 16]. This is true in 
Africa, and Cameroon in particular, where research on 
the disease is inadequate. A PubMed search over the 
last 10 years revealed 13 papers on schistosomiasis from 
Cameroon, with only two of these papers focused on S. 
haematobium. Furthermore, the failure to control and 
eradicate schistosomiasis which is one of the NTDs, 
could be associated with the failure to achieve the Mil-
lennium Development Goal (MDG) 6 in most devel-
oping countries endemic to the disease in Africa like 
Cameroon.
Cameroon adopted a plan in 2004 to combat schisto-
somiasis and soil transmitted helminthiasis (STH) which 
was implemented in all ten regions by the year 2007. 
Annual national deworming campaigns were executed 
with administration of albendazole or mebendazole to 
school-aged children, whereas the distribution of prazi-
quantel was only to highly endemic for schistosomiasis 
[17]. In order to control NTDs, the Cameroonian gov-
ernment implemented an integrative approach which 
involves co-implementing other control intervention 
measures and co-administering several drugs like iver-
mectin, praziquantel, mebendazole and albendazole. 
Since 2009, Cameroon receives assistance from the 
United States Agency for International Development 
(USAID) through its NTD Control Program, currently 
ENVISION program, managed by Response to Interven-
tion (RTI) International. ENVISION facilitates incorpo-
ration of national programs and reinforces mass drug 
administration (MDA) [18].
However, the control data of schistosomiasis in Cam-
eroon is not encouraging. A study carried out in 2013 by 
Tchuenté et al. showed an increase in transmission foci of 
schistosomiasis compared to previous data in 1985–1987 
[19].
The above program therefore has some gaps in health 
policies as accentuated by the case reports above. These 
gaps need to be addressed in order to attain the newly set 
Sustainable Development Goals (SDGs) amongst which 
the control and eradication of Schistosomiasis and other 
NTDs (SDG 3) remains a priority [20].
Due to poor accessibility of most remote areas most 
individuals inhabiting these zones do not receive treat-
ment. Also, out-of-school children are not reached 
and preschoolers and adults are not being treated. The 
annual distribution of praziquantel is therefore defective 
in controlling and/or eradicating schistosomiasis. Both 
patients in this case series lived in North West region 
of Cameroon; in areas with poor accessibility. They 
and several other members of their community did not 
receive preventive chemotherapy though they lived in 
schistosomiasis-endemic zones. Moreso, distribution of 
prazinquantel is only in highly endemic zones obtained 
from data 28 years ago. However, there are rapid reinfec-
tion rates in high transmission settings due to intense 
water contact. Control programs are supposed to be 
coupled with intense monitoring to assess the impact of 
these interventions. This is however not the case in Cam-
eroon. Hence, newly endemic zones cannot be identi-
fied and individuals with the disease go undiagnosed for 
long periods without access to preventive chemotherapy. 
Furthermore, there’s the complete absence of environ-
mental control program (snail control and sanitation 
improvement) which when added to annual drugs dis-
tribution may go a long in disease control and eventually 
disease eradication [21]. Also, the Cameroonian popula-
tion is deficient in knowledge concerning schistosomia-
sis including; the mode of transmission, prevention like 
avoiding wading, swimming, or others contacts with 
fresh water, and treatment with praziquantel. The patient 
in case 1 above experienced disabling symptoms for over 
3 years and only arrived the hospital at a later stage with 
an irreversible complication. Population education on the 
symptoms of the disease and its prevention would lead to 
better health-seeking behaviors and progress in eventual 
control of the disease. Finally, the patient in case 2 expe-
rienced the disabling conditions of the disease for over 
1  year despite several consults at health facilities. This 
calls for the need for training of healthcare providers on 
the recognition and management of NTDs like onchocer-
ciasis [22] and schistosomiasis in Cameroon.
Conclusion
Schistosomiasis is still a major public health problem 
in Cameroon, associated with significant morbidity and 
mortality. Individuals, especially school-aged children, 
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adolescents and young adults in endemic zones are at an 
increased risk to the debilitating conditions of this dis-
ease. As shown above, the current health policies have to 
be revisited and more research has to be done regularly 
to map out new endemic zones in Cameroon in order 
to help with the control of the disease and the eventual 
achievement of the SDGs.
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